Identifying components in consent information needed to support informed decision making about trial participation (UK) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, June 06, 2016

Identifying components in consent information needed to support informed decision making about trial participation (UK)



abstract:
Identifying components in consent information needed to support informed decision making about trial participation: An interview study with women managing cancer 

Soc Sci Med. 2016 May 27

Highlights

We focus on adequacy of consent information in enabling informed trial decisions.
Choices were made in context of illness management, not ‘research participation’ alone.
There was little evidence of active reasoning between trial participation and standard care.
Trial information should support informed decision between trial participation and standard care.

Abstract

Background

Research governance requires patients give informed consent to participate in clinical trials. However, there are concerns that consent information may not support patient participation decisions. This study investigates the utility of consent information in supporting women’s trial participation decisions when receiving treatment for cancer.

Design

An interview study with women receiving cancer treatments at a medical oncology outpatient clinic in Yorkshire (UK). All women over 18 years, not admitted to a hospital ward and who had currently or previously been invited to take part in a trial were invited to take part in the study over a three month period. Interviews were audio-tape recorded, transcribed and analysed using thematic analysis.

Results

Of those eligible (n = 41), 21 women with breast (n = 11), ovarian (n = 8) and endometrial (n = 2) cancer participated (mean age = 57 years). Eighteen had made at least one trial decision and three were considering taking part in a trial. Findings are synthesised under two analytical themes: 1) Influence of the cancer and cancer treatment context on decision making for trial participation; and 2) Experiences of the consenting process and their influence on decision making.

0 comments :

Post a Comment

Your comments?